Formulation: A solid
Formal Name: N-(2-aminoethyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-acetamide
Purity: ≥98%
Formula Markup: C21H28N6O4
Formula Weight: 428,5
Shelf life (days): 1460
CAS Number: 96865-92-8
Notes: Xanthine amine congener (XAC) is a non-selective adenosine receptor antagonist with Kb values of 83, 25, and 15 nM for rat PC12 cells, human platelets that endogenously express adenosine A2A receptors, and rat fat cells that endogenously express A1 receptors, respectively.{41674} It reduces adenylate cyclase activity stimulated by 5'-N-ethylcarboxamidoadenosine (NECA; Item No. 21420) in human platelets (EC50s = 1 and 0.31 μM in the presence and absence of XAC, respectively). XAC also reverses R-PIA-induced inhibition of isoproterenol-stimulated adenylate cyclase activity in rat fat cell membranes (IC50s = 146 and 26 nM in the presence and absence of XAC, respectively). In vivo, XAC reverses reductions in heart rate and blood pressure induced by 2-chloro-3-deazaadenosine (2-CADO; Item No. 9000787), R-PIA, and NECA in rats when administered at doses ranging from 0.1 to 1.0 mg/kg.{41675} XAC (39.8 mg/kg) also induces convulsions in mice.{41676}
English
Deutsch
